news PharmAust (ASX:PAA) doses first patient of MND trial’s second cohort – The Market Herald alex mun February 22, 2023 1 min read source Chat read-only to anonymous users. Chat with Anyone and Anywhere. Only registered users are allowed to send messages. Loading the chat ... 71028 Register Login Continue Reading Previous: China-owned nickel smelter in Indonesia resumes production after … – benarnewsNext: Alert: Israel’s new legal proposals pose ‘serious risks’, UN rights chief warns Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ